• Ardelyx Inc (NASDAQ: ARDX) Corrects after the Pricing of a Public Offering for 20 Million Shares

    Ardelyx Inc is a biopharmaceutical company that develops and sells treatments for cardiorenal diseases. It has its headquarters in Fremont, California.

    Read More
  • 0 0